Trial Profile
An Open-label Study of Etanercept (Enbrel) Efficacy in Ankylosing Spondylitis
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 14 Feb 2011 New trial record